Science Times Observer: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Times Observer.

Press releases published on November 2, 2026

Nov. 2, 2026

Capital Power reports third quarter 2026 results

Indeterminate GlobeNewswire

Nov. 2, 2026

Krystal Biotech Announces Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Nov. 2, 2026

Fredonia Confirms Continuity of Gold/Silver Mineralization and the Potential Expansion of the Conceptual EDM Mine Plan at Herradura Hill

Indeterminate GlobeNewswire

Nov. 2, 2026

Climb Bio to Present at Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 2, 2026

Rapport Announces Closing of Public Offerings of Common Stock and Pre-Funded Warrants and Convertible Notes, Including Full Exercise of Underwriters’ Options to Purchase Additional Shares and Notes, as well as Concurrent Private Placement

Indeterminate GlobeNewswire

Nov. 2, 2026

Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 2, 2026

Major Drilling Acquires Bunbury Drilling Company, Expanding into Specialized Mine Dewatering in Australia

Indeterminate GlobeNewswire

Nov. 2, 2026

Beeline Medicines Initiates First Trial in Lupus Pivotal Development Program with Global Phase 2/3 DISCOVERY Trial of Afimetoran in Cutaneous Lupus Erythematosus (CLE)

Indeterminate GlobeNewswire

Nov. 2, 2026

Hinge Bio to Present Latest Results of HB2198, a Novel B-Cell Depleting Agent for Treating Autoimmune Disease, at ACR Convergence 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Ocular Therapeutix™ to Report Third Quarter 2026 Financial Results on November 9, 2026

Indeterminate GlobeNewswire

Nov. 2, 2026

Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth

Indeterminate GlobeNewswire

Nov. 2, 2026

Harrow Launches HarrowRx Platform

Indeterminate GlobeNewswire

Nov. 2, 2026

Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November

Indeterminate GlobeNewswire

Nov. 2, 2026

POET Technologies Names Giovanni Pacelli CFO

Indeterminate GlobeNewswire

Nov. 2, 2026

Rocket Doctor Expands into Florida, Building Upon Success in California, New York, and Maryland

Indeterminate GlobeNewswire

Nov. 2, 2026

WRAP Taps Former NYPD Chief Behind Narcan Rollout to Scale BolaWrap and Operationalize De-Escalation

Indeterminate GlobeNewswire

Nov. 2, 2026

SUNation Energy Announces Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Merger with Suniva

Indeterminate GlobeNewswire

Nov. 2, 2026

Spectral Medical Inc. Announces Closing of First Tranche of $14.0 Million Convertible Note Private Placement, Conversion of US$4.5 Million of Maturing Convertible Notes and Repayment of US$4.5 Million of Maturing Convertible Notes

Indeterminate GlobeNewswire

Nov. 2, 2026

Tonix Pharmaceuticals Appoints George Lederman, Ph.D., as Executive Vice President of Strategy and Transformation

Indeterminate GlobeNewswire

Nov. 2, 2026

Tower Semiconductor Reports Third Quarter Record Results, Providing Record Fourth Quarter Guidance Resulting in 2026 $2 Billion Annual Revenue

Indeterminate GlobeNewswire